Phosphodiesterase 10A as a Therapeutic Target in Neuropsychopharmacology: A Review

Phosphodiesterase 10A as a Therapeutic Target in Neuropsychopharmacology: A Review

INTRODUCTION. Phosphodiesterases (PDEs) are enzymes that regulate intracellular signalling by catalysing the hydrolysis of cyclic nucleotides. The commercial success of selective PDE5 inhibitors for erectile dysfunction and PDE4 inhibitors for respiratory and skin diseases has drawn the close attent...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. R. Dorotenko, I. M. Sukhanov, G. V. Iskarevskii, A. S. Ulitina, A. A. Savchenko, M. А. Tur
Format:	Article
Language:	Russian
Published:	Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2025-05-01
Series:	Регуляторные исследования и экспертиза лекарственных средств
Subjects:	phosphodiesterase pde pde10a inhibitors neuropsychopharmacology pharmaceutical development cortico-striato-thalamo-cortical circuits
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/723
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetically proxied inhibition of Phosphodiesterase-5 and cancer risks: A drug-target Mendelian randomization analysis
by: Kefu Tang, et al.
Published: (2025-07-01)

Phosphodiesterase type 5 inhibitors and erectile dysfunction
by: Catherine Whittaker
Published: (2010-06-01)

Membrane-Mediated Action of Phosphodiesterase 5 Inhibitors
by: Anna I. Malykhina, et al.
Published: (2025-04-01)

Neural operator for observer gains and output-feedback control of coupled PDE–ODE systems
by: Malihe Abdolbaghi, et al.
Published: (2025-08-01)

MANAGEMENT OF ERECTILE DYSFUNCTION IN CARDIOVASCULAR PATIENTS WITH COMORBIDITIES: REVIEW OF THE TRIALS ON CONTINUING THERAPY WITH PHOSPHODIESTERASE-5 MEDICATIONS
by: G. G. Sharvadze, et al.
Published: (2018-06-01)

Determination of Phosphodiesterase Type 5 Enzyme (PDE-5) Inhibitors and Analogues as Adulterants in Selected Herbal Products using Gas Chromatography–Electron Impact-Mass Spectrometer (GC-EI-MS)
by: Nur Azzalia Kamaruzaman, et al.
Published: (2020-12-01)

Anomalous transport models for fluid classification: insights from an experimentally driven approach
by: Sara Bernardi, et al.
Published: (2025-08-01)

Case Report: The widening genetic and phenotypic spectrum of ultra-rare PDE4D-related acroscyphodysplasia
by: Anna Morgul, et al.
Published: (2025-08-01)

Vascular remodeling in arteriovenous fistula treated with PDE5A inhibitors
by: Maheshika Somarathna, et al.
Published: (2025-05-01)

Regiones del cromosoma 5 asociadas a características de crecimiento en ganado criollo romosinuano
by: R. M. Ríos, et al.
Published: (2010-01-01)

Considerations for Permitted Daily Exposure Calculation for Contaminants in Medicinal Products Manufactured in Shared Facilities
by: A. G. Solodovnikov, et al.
Published: (2022-10-01)

The place of a phosphodiesterase 4 inhibitor in the treatment strategy for psoriatic arthritis
by: V. I. Mazurov, et al.
Published: (2018-04-01)

A review of phosphodiesterase type 5 inhibitors
by: N. Schellack, et al.
Published: (2014-05-01)

On the solution of the coupled Whitham–Broer–Kaup problem using a hybrid technique for improved accuracy
by: Dilveen M. Ahmed, et al.
Published: (2025-06-01)

Conservation laws that depend on functions and PDE reduction: Extending Noether $1\tfrac {1}{2}$
by: Peter E. Hydon, et al.

PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
by: M. N. Mamedov, et al.
Published: (2016-01-01)

The improved thalamo-cortical spiking network model of deep brain stimulation
by: AmirAli Farokhniaee, et al.
Published: (2025-08-01)

APPROACHES TO SELECTION OF REVASCULARIZED CORTICO-PERIOSTAL AUTOTRANSPLANTS IN RECONSTRUCTIVE SURGERY OF THE EXTREMITIES
by: N. O. Milanov, et al.
Published: (2010-03-01)

Glowinski and numerical control problems
by: Fernández-Cara, Enrique
Published: (2023-04-01)

An adaptive least-squares algorithm for the elliptic Monge–Ampère equation
by: Caboussat, Alexandre, et al.
Published: (2023-10-01)

Luteolin prevents fMLP-induced neutrophils adhesion via suppression of LFA-1 and phosphodiesterase 4 activity
by: Dai-xun JIANG, et al.
Published: (2015-01-01)

Potent β-lactam-based tyrosyl-DNA phosphodiesterase 1 inhibitors identified by a virtual screen
by: Xue Zhi Zhao, et al.
Published: (2025-07-01)

COENZYME Q<sub>10</sub> IN THE COMPLEX TREATMENT OF ARTERIAL HYPERTENSION
by: Yu. P. Pereponov
Published: (2011-10-01)

Informative value of neurophysiological and neuroimaging research methods in the onset of spinal cord myelopathy: literature review and clinical observation
by: D. S. Kanshina, et al.
Published: (2022-02-01)

PDE3A as a Therapeutic Target for the Modulation of Compartmentalised Cyclic Nucleotide-Dependent Signalling
by: Swaroop Ranjan Pati, et al.
Published: (2025-05-01)

Topical Crisaborole for the Treatment of Recalcitrant Palmoplantar Pustulosis: A Case Series
by: Yen-Yi Sung, et al.
Published: (2025-04-01)

The efficacy of apremilast in pemphigus: a systematic review of case reports
by: Roudin Hussain Alhasawi, et al.
Published: (2025-05-01)

Hypertension and sexual dysfunction
by: J.A. Ker
Published: (2012-04-01)

Apremilast Coadministered with Secukinumab for Effective Treatment of Acrodermatitis Continua of Hallopeau: A Case Report
by: Yao XY, et al.
Published: (2025-05-01)

Altered gray matter morphometry in psychogenic erectile dysfunction patients: A Surface-based morphometry study
by: Zilei Tian, et al.
Published: (2025-08-01)

Sublinear association between cortical thickness at the onset of the adult lifespan and age-related annual atrophy parallels spatial patterns of laminar organization in the adult cerebral cortex
by: Bruno Hebling Vieira, et al.
Published: (2021-06-01)

The relationship between the thickness of the buccal and palatal cortical bone surrounding the maxillary third molars and the corresponding dimensions of the maxillary tuberosity: a retrospective cross-sectional study
by: Mohammed Amjed Alsaegh, et al.
Published: (2025-07-01)

Clinical experience with apremilast for psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2018-09-01)

THE EFFICACY AND SAFETY OF THE NEW DRUG APREMILAST FOR THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS
by: Yu. L. Korsakova, et al.
Published: (2016-12-01)

The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
by: Cheng-Der Liu, et al.
Published: (2021-01-01)

DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME IN A PATIENT SUFFERING FROM CLASSIC CONGENITAL ADRENAL CORTICAL HYPERPLASIA
by: L. A. IVANOV, et al.
Published: (2017-12-01)

Analyzing food supplements to enhance erectile system function for the presence of undeclared sildenafil and tadalafil using HPLC-DAD
by: Bozhinoska Zorica, et al.
Published: (2025-01-01)

Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
by: Chun-Chun Chang, et al.
Published: (2020-01-01)

Exploring the COMPIN-10 and SUCOMP-10 Scales: Measuring Inferiority and Superiority Complexes Across Nine Countries
by: Đorđe Čekrlija, et al.
Published: (2025-07-01)

Exploring the COMPIN-10 and SUCOMP-10 Scales: Measuring Inferiority and Superiority Complexes Across Nine Countries
by: Đorđe Čekrlija, et al.
Published: (2025-07-01)